Atlas Trials

Safety and Efficacy Study of Contezolid Acefosamil and Contezolid Compared to Linezolid Administered Intravenously and Orally to Adults With Moderate or Severe Diabetic Foot Infections (DFI)

Clinical trial NCT05369052 · RECRUITING

Trial details

NCT number
NCT05369052
Sponsor
MicuRx
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Diabetic Foot Infection
Start date
2022-05-03
Primary completion
2026-06-30
Enrollment
865

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.